13F filer · CIK 1931118
SUPERSTRING CAPITAL MANAGEMENT LP
NEW YORK, NY · filing since Q4 2023 · last filing Aug 14, 2026
Reported value
$158.4M
+$18.4M vs prior
Positions
32
New / sold out
8 / 11
Added / reduced
13 / 9
Turnover
40.6%
buys $60.6M · sells $76.3M
Top-10 weight
63.8%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | AXSOME THERAPEUTICS INC. | +42,699 | +380.7% | +$10.5M |
| New | REVOLUTION MEDICINES INC | +51,053 | – | +$9.6M |
| Added | GENMAB A/S | +233,891 | +118.9% | +$6.4M |
| Added | TREVI THERAPEUTICS INC | +272,658 | +108.4% | +$5.1M |
| Added | COGENT BIOSCIENCES INC | +118,126 | +52.5% | +$4.6M |
| Added | CLIMB BIO INC | +321,873 | +161.6% | +$4.2M |
| Added | CELLDEX THERAPEUTICS INC NEW | +107,535 | +59.7% | +$4.0M |
| New | BEONE MEDICINES LTD | +12,273 | – | +$3.5M |
| Added | ORIC PHARMACEUTICALS INC | +290,843 | +252.4% | +$3.1M |
| Added | ADLAI NORTYE LTD | +137,649 | +33.2% | +$1.6M |
11 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | SUMMIT THERAPEUTICS INC | -892,873 | -100.0% | $-16.9M |
| Reduced | DEFINIUM THERAPEUTICS INC | -163,179 | -46.4% | $-7.7M |
| Reduced | UROGEN PHARMA LTD | -196,058 | -50.6% | $-7.2M |
| Reduced | IMMUNOVANT INC | -149,238 | -41.7% | $-5.8M |
| Sold out | VERTEX PHARMACEUTICALS INC | -11,010 | -100.0% | $-4.9M |
| Sold out | IQVIA HLDGS INC | -25,668 | -100.0% | $-4.4M |
| Reduced | SAVARA INC | -608,517 | -38.4% | $-3.7M |
| Reduced | SIONNA THERAPEUTICS INC | -77,868 | -55.2% | $-3.4M |
| Sold out | ARVINAS INC | -312,620 | -100.0% | $-3.3M |
| Sold out | ORUKA THERAPEUTICS INC | -63,591 | -100.0% | $-3.1M |
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | COGENT BIOSCIENCES INCCOM | 343,284 | $13.3M | 8.39% |
| 2 | AXSOME THERAPEUTICS INC.COM | 53,916 | $13.2M | 8.33% |
| 3 | GENMAB A/SSPONSORED ADS | 430,600 | $11.8M | 7.47% |
| 4 | CELLDEX THERAPEUTICS INC NEWCOM NEW | 287,583 | $10.7M | 6.76% |
| 5 | TREVI THERAPEUTICS INCCOM | 524,224 | $9.8M | 6.17% |
| 6 | REVOLUTION MEDICINES INCCOM | 51,053 | $9.6M | 6.04% |
| 7 | DEFINIUM THERAPEUTICS INCCOM SHS | 188,282 | $8.9M | 5.59% |
| 8 | VIR BIOTECHNOLOGY INCCOM | 853,685 | $8.7M | 5.49% |
| 9 | IMMUNOVANT INCCOM | 208,368 | $8.0M | 5.07% |
| 10 | UROGEN PHARMA LTDCOM | 191,313 | $7.0M | 4.45% |
22 more rows. Subscribe for $29/month to see every row, download the data and use the API.